Quantcast
Last updated on April 16, 2014 at 7:10 EDT

Latest Pulmonology Stories

2013-07-17 08:26:28

BRISBANE, Calif., July 17, 2013 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that it will release its second quarter 2013 financial results at the close of the U.S. markets on Wednesday, July 24, 2013. A live conference call and webcast will be hosted by InterMune at 4:30 p.m. Eastern time that same day. (Logo: http://photos.prnewswire.com/prnh/20120827/SF62570LOGO) Interested investors and others may participate in the conference call by dialing 800-891-8257...

2013-07-02 23:20:44

The 4th of July is only a couple of days away and Pulmonary and Critical Care Specialists of Northern Virginia, P.C. want to make sure that you are taking extra preventative measures when it comes to you and your asthma. Fairfax, VA (PRWEB) July 02, 2013 When it comes to you and your asthma, it is important to be able to identify your asthma triggers and the proper steps to help avoid them. Asthma triggers can irritate your asthma symptoms – coughing, wheezing, and difficulty catching...

2013-07-02 08:26:02

BRISBANE, Calif., July 2, 2013 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that Dan Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the JMP Securities Healthcare Conference in New York City on July 9, 2013, at 1:30 p.m. EDT. (Logo: http://photos.prnewswire.com/prnh/20120827/SF62570LOGO) To access a live audio webcast of the presentation, investors and other interested parties may log on to the investor relations page of...

2013-07-01 19:12:08

The American Thoracic Society has released an official statement on the ethical and health policy considerations surrounding adult and pediatric controlled organ donation after circulatory determination of death (DCDD), the recovery of organs after cessation of circulation from patients with severe neurological, neuromuscular or pulmonary disease for whom decisions are made to forego additional life-prolonging treatments. The ATS developed the statement with input from the Society of...

2013-07-01 08:27:49

Payers are Most Receptive to Reimbursing Premium-Priced Novel Therapies that Offer Clinical Improvements in the Rate of Severe Exacerbations, According to a New Report from Decision Resources BURLINGTON, Mass., July 1, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed pulmonologists in the United States and Europe agree that a drug's effect on reducing the exacerbation rate is...

2013-07-01 04:20:35

LONDON, July 1, 2013 /PRNewswire/ -- Verona Pharma plc (AIM: VRP), the drug development company focused on "first-in-class" medicines to treat respiratory diseases, announces that a paper entitled "The effect of the mixed phosphodiesterase 3/4 inhibitor RPL554 on human isolated bronchial smooth muscle tone" is now available on-line in the Journal of Pharmacology and Experimental Therapeutics.[1] Importantly, the reported results highlight the potential opportunity to combine...

2013-06-28 13:14:00

Children with more genetic risks for asthma are not only more likely to develop the condition at a young age, but they are also more likely to continue to suffer with asthma into adulthood. The finding reported by Duke University researchers is one of the latest to come from a 40-year longitudinal study of New Zealanders. "We've been able to look at how newly discovered genetic risks relate to the life course of asthma at an unprecedented level of resolution," said Daniel Belsky, a...

2013-06-25 23:19:03

Coming Soon July 2013, PCCSNOVA is Opening a New Office Location In Haymarket, Virginia. Fairfax, VA (PRWEB) June 25, 2013 Pulmonary and Critical Care Specialists of Northern Virginia, P.C. is pleased announce the opening of their second Prince William County office. Their board certified physicians have been recognized as "top doctors" by Northern Virginia Magazine and Washingtonian. Doctors George Bazaco, Maura Foley and Kevin Glass will be providing services at their new...

2013-06-20 08:25:52

Collaboration intended to advance techniques in modification of bronchial smooth muscle SAUSALITO, Calif., June 20, 2013 /PRNewswire/ -- Sanovas, Inc., a leading developer of micro invasive surgical solutions for the Interventional Pulmonary Science, announced today that it has entered into a patent license and joint development agreement with Mayo Clinic to commercialize a significant innovation in the emerging science of bronchial smooth muscle modification. The collaboration is...

2013-06-17 08:28:01

MISSISSAUGA, ON, June 17, 2013 /CNW/ - A second analysis of data from real-world study PATHOS, recently published in the British Medical Journal, shows that treatment of chronic obstructive pulmonary disease (COPD) patients with SYMBICORT(®) (budesonide/formoterol) was associated with a lower incidence of pneumonia and pneumonia related death, compared to treatment of COPD patients with ADVAIR(®) (fluticasone/salmeterol).(i) PATHOS is the largest real-world study to compare the...


Latest Pulmonology Reference Libraries

0_f9fe10c6664d20ba0d9091907b66a65f
2011-01-05 16:00:36

Human parainfluenza viruses, belonging to the paramyxovirus family, are a group of four distinct serotypes of enveloped single-stranded RNA viruses. They are the second most common cause of lower respiratory tract infection in younger children. Many times the host has repeat infections throughout life with symptoms that may include upper respiratory tract illness or more commonly, a cold and sore throat. It can also cause severe pneumonia in immunosuppressed people. There is currently no...

More Articles (1 articles) »